ID   585A1
AC   CVCL_DQ06
SY   HPS0354
DR   GEO; GSM1040279
DR   GEO; GSM1040349
DR   GEO; GSM1489230
DR   GEO; GSM1489447
DR   GEO; GSM2152683
DR   GEO; GSM2152684
DR   GEO; GSM2152685
DR   GEO; GSM2152686
DR   GEO; GSM2152687
DR   GEO; GSM2152688
DR   GEO; GSM2152689
DR   GEO; GSM2152690
DR   GEO; GSM2592208
DR   GEO; GSM2592209
DR   PRIDE; PXD000071
DR   RCB; HPS0354
DR   SKIP; SKIP000858
DR   Wikidata; Q54603888
RX   Patent=US20200407693;
RX   PubMed=22802639;
RX   PubMed=23193063;
RX   PubMed=23210603;
RX   PubMed=24259714;
RX   PubMed=25665923;
RX   PubMed=26189426;
RX   PubMed=27476965;
RX   PubMed=28453617;
RX   PubMed=30735882;
RX   PubMed=30853558;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*07:02,52:01; C*07:02,12:02; DRB1*01:01,15:01 (PubMed=30853558).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DQ07 ! 585B1
OI   CVCL_DQ20 ! 692D2
OI   CVCL_LJ36 ! 692E1
OI   CVCL_DQ21 ! 703A1
OI   CVCL_DQ22 ! 703B1
SX   Male
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
RX   Patent=US20200407693;
RA   Hotta A., Xu H.-G., Kaneko S., Wang B.;
RT   "Method for producing low-antigenic cell.";
RL   Patent number US20200407693, 31-Dec-2020.
//
RX   PubMed=22802639; DOI=10.1073/pnas.1209979109; PMCID=PMC3411998;
RA   Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N.,
RA   Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.;
RT   "Donor-dependent variations in hepatic differentiation from
RT   human-induced pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012).
//
RX   PubMed=23193063; DOI=10.1002/stem.1293;
RA   Okita K., Yamakawa T., Matsumura Y., Sato Y., Amano N., Watanabe A.,
RA   Goshima N., Yamanaka S.;
RT   "An efficient nonviral method to generate integration-free
RT   human-induced pluripotent stem cells from cord blood and peripheral
RT   blood cells.";
RL   Stem Cells 31:458-466(2013).
//
RX   PubMed=23210603; DOI=10.1021/pr300837u;
RA   Yamana R., Iwasaki M., Wakabayashi M., Nakagawa M., Yamanaka S.,
RA   Ishihama Y.;
RT   "Rapid and deep profiling of human induced pluripotent stem cell
RT   proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic
RT   silica columns.";
RL   J. Proteome Res. 12:214-221(2013).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110; PMCID=PMC3870695;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=25665923; DOI=10.1016/j.scr.2015.01.007;
RA   Toyoda T., Mae S.-i., Tanaka H., Kondo Y., Funato M., Hosokawa Y.,
RA   Sudo T., Kawaguchi Y., Osafune K.;
RT   "Cell aggregation optimizes the differentiation of human ESCs and
RT   iPSCs into pancreatic bud-like progenitor cells.";
RL   Stem Cell Res. 14:185-197(2015).
//
RX   PubMed=26189426; DOI=10.1016/j.stem.2015.06.014;
RA   Sasaki K., Yokobayashi S., Nakamura T., Okamoto I., Yabuta Y.,
RA   Kurimoto K., Ohta H., Moritoki Y., Iwatani C., Tsuchiya H.,
RA   Nakamura S., Sekiguchi K., Sakuma T., Yamamoto T., Mori T.,
RA   Woltjen K., Nakagawa M., Yamamoto T., Takahashi K., Yamanaka S.,
RA   Saitou M.;
RT   "Robust in vitro induction of human germ cell fate from pluripotent
RT   stem cells.";
RL   Cell Stem Cell 17:178-194(2015).
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M.,
RA   Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M.,
RA   Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A.,
RA   Yamanaka S., Yoshida Y.;
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//
RX   PubMed=28453617; DOI=10.1093/biolre/iox038;
RA   Yokobayashi S., Okita K., Nakagawa M., Nakamura T., Yabuta Y.,
RA   Yamamoto T., Saitou M.;
RT   "Clonal variation of human induced pluripotent stem cells for
RT   induction into the germ cell fate.";
RL   Biol. Reprod. 96:1154-1166(2017).
//
RX   PubMed=30735882; DOI=10.1016/j.scr.2019.101400;
RA   Matsui S., Ochiai M., Yasuda K., Mae S.-i., Kotaka M., Toyoda T.,
RA   Yamamoto T., Osafune K.;
RT   "Differentiation and isolation of iPSC-derived remodeling ductal
RT   plate-like cells by use of an AQP1-GFP reporter human iPSC line.";
RL   Stem Cell Res. 35:101400-101400(2019).
//
RX   PubMed=30853558; DOI=10.1016/j.stem.2019.02.005;
RA   Xu H.-G., Wang B., Ono M., Kagita A., Fujii K., Sasakawa N., Ueda T.,
RA   Gee P., Nishikawa M., Nomura M., Kitaoka F., Takahashi T., Okita K.,
RA   Yoshida Y., Kaneko S., Hotta A.;
RT   "Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with
RT   enhanced immune compatibility.";
RL   Cell Stem Cell 24:566-578.e7(2019).
//